Skip to content

Efficacy of Oral Appliance for Upper Airway Resistance Syndrome

Efficacy of Oral Appliance for Upper Airway Resistance Syndrome: Randomized, Parallel, Placebo, Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02636621
Enrollment
60
Registered
2015-12-22
Start date
2013-10-31
Completion date
2017-10-31
Last updated
2016-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Airway Resistance Syndrome

Keywords

Fatigue, excessive daytime sleepiness, flow limitation

Brief summary

Introduction: The Upper Airway Resistance Syndrome (UARS) is a sleep disorder characterized by airway resistance to breathing during sleep that leads to arousals and daytime sleepiness. There are few studies about UARS treatment and there is not any gold standard treatment for it yet. Objective: Primary: To evaluate the efficacy of oral appliance on improving fatigue in patients with UARS. Secondary: Evaluate the effects of treatment with oral appliance (OA) in patients with UARS on sleepiness, mood, cognition, quality of life, metabolism and autonomic nervous system. Methods: Subjects with UARS (Apnea/Hypopnea Index - AHI - ≤ 5 events per hour of sleep and Respiratory Disturbance Index - RDI - \> 5 events per hour or more than 30% of total sleep time with inspiratory flow limitation and with excessive daytime somnolence and/or fatigue) of both genders, with body mass index (BMI) lower than 30Kg/m2 and between 25 to 50 years of age will be included. Subjects will be randomly distributed in OA group and placebo (without treatment). At baseline evaluation, 6 months and 1 year after subjects will be submitted to sleep questionnaires, physical exam, otolaryngological evaluation, baseline polysomnography, Epworth sleepiness scale, Multiple Sleep Latency Test, fatigue scale, neurocognitive testing, autonomic nervous system analysis (heart rate variability) and metabolic evaluation. Mean and standard deviation will be used for descriptive statistical analysis if normal distribution, and median and percentiles (25%, 75%) for variables not normally distributed. To compare treatment groups T test (parametric) and Mann Whitney (non parametric) will be used. For adjusted analysis, linear regression analysis will be used.

Interventions

DEVICEBrazilian Dental Appliance

Brazilian Dental Appliance is an oral appliance worn only during sleep that supports the jaw in a forward position to help maintain an open upper airway.

OTHERPlacebo

The placebo consists in a protective dental plate worn only during sleep that do not interfere in the size of the upper airway.

Sponsors

Associação Fundo de Incentivo à Pesquisa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
25 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Both genders * Body mass index (BMI) ≤ 30Kg/m2 * Age from 25 to 50 years * Clinical and polysomnographic diagnosis of Upper Airway Resistance Syndrome: Apnea/Hypopnea Index (AIH) ≤ 5 events/hour and Respiratory Disturbance Index (RDI) \> 5 events/hour or \> 30% of total sleep time with inspiratory flow limitation with excessive daytime somnolence or fatigue

Exclusion criteria

* Unsatisfactory dental condition or severe temporomandibular disfunction; * Nasal obstruction; * Alcohol abuse and excessive consumption of psychotropic drugs; * Clinical, neurological or psychiatric diseases not treated * Less than 6 hours of sleep

Design outcomes

Primary

MeasureTime frameDescription
FatigueFrom the baseline evaluation to one year after the treatment with oral applianceModified fatigue impact scale for Portuguese (MFIS- BR)

Secondary

MeasureTime frameDescription
Objective excessive daytime sleepinessFrom the baseline evaluation to one year after the treatment with oral applianceMultiple Sleep Latency Test
Mood - AnxietyFrom the baseline evaluation to one year after the treatment with oral applianceBeck inventories (BAI)
Mood - DepressionFrom the baseline evaluation to one year after the treatment with oral applianceBeck inventories (BDI)
Sustained attentionFrom the baseline evaluation to one year after the treatment with oral appliancePsychomotor Vigilance Test (PVT)
Cognition - MemoryFrom the baseline evaluation to one year after the treatment with oral applianceDigit Symbol Substitution Test (DSST)
Cognition - Learning strategiesFrom the baseline evaluation to one year after the treatment with oral applianceRey Auditory-Verbal Learning Test (RAVLT)
Cognition - Immediate and late memoriesFrom the baseline evaluation to one year after the treatment with oral applianceWechsler Memory Scale (WMS)
Subjective excessive daytime sleepinessFrom the baseline evaluation to one year after the treatment with oral applianceEpworth sleepiness scale
Cognition - Visual attentionFrom the baseline evaluation to one year after the treatment with oral applianceTrail Making Test - TMT
Quality of sleepFrom the baseline evaluation to one year after the treatment with oral appliancePittsburgh Sleep Quality Index (PSQI)
Quality of lifeFrom the baseline evaluation to one year after the treatment with oral applianceFunctional Outcomes of Sleep Questionnaire (FOSQ)
StressFrom the baseline evaluation to one year after the treatment with oral applianceTeste de Lipp
MetabolismFrom the baseline evaluation to one year after the treatment with oral applianceBlood analysis of metabolism
Autonomic nervous system analysisFrom the baseline evaluation to one year after the treatment with oral applianceHeart rate variability
Cognition - Processing speed abilityFrom the baseline evaluation to one year after the treatment with oral applianceStroop Color Test

Countries

Brazil

Contacts

Primary ContactLUCIANA GODOY, MD
lu_bmg@yahoo.com.br551121490155

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026